Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
285 CAD | 0.00% | 0.00% | -8.06% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 04 | Biolinq Incorporated announced that it has received $58 million in funding from a group of investors | CI |
Sales 2022 | -740M -541M | Sales 2023 | 427M 312M | Capitalization | 766M 560M |
---|---|---|---|---|---|
Net income 2022 | -326M -238M | Net income 2023 | 83M 60.67M | EV / Sales 2022 | 4.28 x |
Net cash position 2022 | 3.97B 2.9B | Net cash position 2023 | 3.43B 2.51B | EV / Sales 2023 | -6.24 x |
P/E ratio 2022 |
-2.47
x | P/E ratio 2023 |
9.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.47% |
3 months | -12.31% | ||
6 months | -4.68% | ||
Current year | -8.06% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | - | |
Victor Mashaal
CHM | Chairman | - | 68-11-19 |
Frank Daniel
BRD | Director/Board Member | - | 71-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Victor Mashaal
CHM | Chairman | - | 68-11-19 |
Richard Mashaal
BRD | Director/Board Member | - | 00-12-31 |
Director/Board Member | - | 14-06-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | - | -100.00% | 28 |
24-04-16 | 285 | +∞% | 0 |
Delayed Quote Toronto S.E., April 16, 2024 at 11:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.06% | 515M | |
-5.57% | 114B | |
-3.22% | 90.81B | |
+15.50% | 64.64B | |
+3.73% | 61.06B | |
+10.37% | 42.95B | |
+7.33% | 40.61B | |
+19.37% | 34.3B | |
+3.97% | 25.03B | |
-3.96% | 22.43B |
- Stock Market
- Equities
- SEC Stock